Sociedad Española de Terapia Génica y Celular
  • Home
  • Policies & advocacy
    • Policies & advocacy
    • Regulatory information
      • GMP Guidelines
    • EMA guidance
    • ESGCT statements
    • Useful links
Home

This week in gene and cell therapy - 10 August 2018

Gene and cell therapy headlines 6 - 10 August


Oxford Biomedica and Boehringer Ingelheim to partner with UK Cystic Fibrosis Gene Therapy Consortium

EvolvR, a new CRISPR based system, drives locus specific mutagenesis

Regeneron and Bluebird bio enter partnership to develop anti-cancer cell therapies

Akouos raises funds to take gene therapy for hearing loss into the clinic

Spark releases data from haemophilia a trial and aims to move into phase 3

Allergan to co-develop and co-commercialise Editas gene therapy for retinal disorder

Sarepta acquires rights to Lacerta Therapeutics CNS gene therapy

Regenxbio releases promising phase I data for wet AMD gene therapy

Astellas increases gene therapy presence by acquiring Quethera

 

Account login

Create a secure accountJoin
Forgotten your details?

Sponsors

Diamond

Platinum

Gold

Silver

Bronze

Copyright © 2023 Sociedad Española de Terapia Génica y Celular Member Area Terms and Conditions user account Privacy Policy Cookies Terms and Conditions membership purchase Terms and Conditions congress registration Terms and Conditions abstract submission Terms and Conditions user account RSS feed Join us Follow us